Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Brain Research|October 26, 2017
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET studyAgostino Chiaravalloti, Gaetano Barbagallo, Maria Ricci, et al.
Biomedicines|January 21, 2022
Detection Rate and Clinical Impact of PET/CT with 18F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric StudyLuca Filippi, Oreste Bagni, Carmelo Crisafulli, et al.
Cancers|June 26, 2026
Radiometabolic Therapy in Lymphoma: From Radioimmunotherapy to Emerging Theranostic and Combination StrategiesAgostino Chiaravalloti, Daniele Di Biagio, Pierpaolo Alongi, et al.
Nuclear Medicine Communications|February 4, 2015
Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT studyAgostino Chiaravalloti, Alessandro Martorana, Giacomo Koch, et al.
Biomed Research International|July 30, 2019
Evaluation of Task-Related Brain Activity: Is There a Role for 18F FDG-PET Imaging?Agostino Chiaravalloti, Alessandro Micarelli, Maria Ricci, et al.
Scientific Reports|July 26, 2017
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT studyAgostino Chiaravalloti, Francesco Ursini, Alessandro Fiorentini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2026
Plasma phosphorylated tau biomarkers map onto [^18F]FDG PET hypometabolism: a voxel-wise study in a clinical cohort with CSF-confirmed AD subgroup analysisAgostino Chiaravalloti, Caterina Motta, Chiara Giuseppina Bonomi, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An OverviewAndrea Cimini, Maria Ricci, Francesca Russo, et al.
Annals of Nuclear Medicine|May 18, 2026
Semiquantitative SSTR PET metrics show molecular-morphologic discordance after 177Lu-DOTATATE in gastroenteropancreatic neuroendocrine neoplasms: an exploratory paired target-lesion analysisAgostino Chiaravalloti, Martina Egidi, Antonio D'Agostini, et al.
Annals of Nuclear Medicine|April 6, 2019
Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?Agostino Chiaravalloti, Vincenzo Esposito, Francesco Ursini, et al.
Pageof 13